Live stream preview
Denosumab Discontinuation in Postmenopausal Osteoporosis Prof Yumie Rhee
ANZBMS (Bone & Mineral) 2023
•
33m
Up Next in ANZBMS (Bone & Mineral) 2023
-
Interface between patient, policy and...
-
Use of denosumab in non-osteoporotic ...
-
Hypophosphatasia in the age of miracl...